Reducing emergency cesarean delivery and improving the primiparous experience: Findings of the RECIPE study.

Cesarean delivery External validation Prediction models Risk prediction Vaginal delivery

Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 02 06 2020
revised: 19 09 2020
accepted: 21 09 2020
pubmed: 17 10 2020
medline: 15 5 2021
entrez: 16 10 2020
Statut: ppublish

Résumé

The ability to predict the need for emergency Cesarean delivery holds the potential to facilitate birth choices. The objective of the RECIPE study (Reducing Emergency Cesarean delivery and Improving the Primiparous Experience) was to externally validate a Cesarean delivery risk prediction model. This model, developed by the Genesis study, identified five key predictive factors for emergency Cesarean delivery: maternal age, maternal height, BMI, fetal head circumference (HC) and fetal abdominal circumference (AC). This prospective, observational study was conducted in two tertiary referral perinatal centers. Inclusion criteria were as follows: primiparous women with a singleton, cephalic presentation fetus in the absence of fetal growth restriction (FGR), oligohydramnios, pre-eclampsia, pre-existing diabetes mellitus or an indication for planned Cesarean delivery. Between 38 + 0 and 40 + 6 weeks' gestational age, participants attended for prenatal assessment that enabled the determination of an individualized risk calculation for emergency Cesarean delivery during labour based on maternal height, BMI, fetal HC and AC, with crucially both participants and care providers being blinded to the resultant risk prediction score. Labor, delivery and postnatal outcomes were ascertained. Calibration and receiver operator curves were generated to determine the predictive capacity for emergency Cesarean delivery of the Genesis risk prediction model in this cohort. 559 primiparous participants were enrolled from May 2017 to April 2019, of whom 142 (25 %) had an emergency Cesarean delivery during labour. Participants with a low predicted risk score (<10 %) had a mean predicted rate of 8% (+/- standard deviation of 2%) and a similarly low actual observed rate of Cesarean delivery (8%). Participants with a high predicted risk (>50 %) had a mean predicted Cesarean delivery rate of 64 % (+/- standard deviation of 9%) and also had a high actual observed Cesarean delivery rate (62 %). The calibration curve and receiver operating characteristic curve demonstrated that this validation study had comparable discriminatory power for emergency Cesarean delivery to that described in the original Genesis study. The Area Under the Curve (AUC) in Genesis was 0.69, whereas the AUC in RECIPE was 0.72, which reflects good predictive capacity of the risk prediction model. The accuracy of the Genesis Cesarean delivery prediction tool is supported by this validation study.

Identifiants

pubmed: 33065516
pii: S0301-2115(20)30613-8
doi: 10.1016/j.ejogrb.2020.09.035
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-19

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Niamh C Murphy (NC)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: nmurphy@rcsi.ie.

Naomi Burke (N)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Patrick Dicker (P)

Epidemiology & Public Health, Royal College of Surgeons in Ireland, Dublin, Ireland.

Fiona Cody (F)

Obstetrics & Gynaecology, Rotunda Hospital, Dublin, Ireland.

Sarah Al Nafisee (SA)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Dylan Deleau (D)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Etaoin Kent (E)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Sunitha Ramaiah (S)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Elizabeth C Tully (EC)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Fergal D Malone (FD)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Fionnuala M Breathnach (FM)

Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH